HandeHayirliogluTuncerMD

PubMed

• 3 citations
  Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.
  Mazyar Shadman, Beenish S Manzoor, Kavita Sail, Hande H Tuncer, John N Allan, Chaitra Ujjani, Nnadozie Emechebe, Rajesh Kamalakar, Catherine C Coombs, Lori Leslie, Pau...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Jul 1
• 9 citations
  The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy.
  Chaitra S. Ujjani, Anthony R. Mato, Brian T. Hill, John N. Allan, Frederick Lansigan, Ryan Jacobs, Alan P Skarbnik, Hande H. Tuncer, John M. Pagel, Danielle M. Brander...> ;Blood and Lymphatic Cancer. 2020 Aug 24
• 6 citations
  Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia
  Toby A. Eyre, Nicole Lamanna, Lindsey E. Roeker, Chaitra S. Ujjani, Brian T. Hill, Paul M. Barr, Erick Lansigan, Bruce D. Cheson, Maryam Sarraf Yazdy, John N. Allan, J...> ;Haematologica. 2020 Feb 20
• 25 citations
  A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.
  Anthony R. Mato, Lindsey E. Roeker, Toby A. Eyre, Chadi Nabhan, Nicole Lamanna, Brian T. Hill, Danielle M. Brander, Paul M. Barr, Frederick Lansigan, Bruce D. Cheson, ...> ;Blood Advances. 2019 May 28
• 51 citations
  Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.
  Lindsey E. Roeker, Christopher P. Fox, Toby A. Eyre, Danielle M. Brander, John N. Allan, Stephen J. Schuster, Chadi Nabhan, Brian T. Hill, Nirav N. Shah, Frederick Lan...> ;Clinical Cancer Research. 2019 Jan 1
• 49 citations
  Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.
  Anthony R. Mato, Lindsey E. Roeker, John N. Allan, John M. Pagel, Danielle M. Brander, Brian T. Hill, Bruce D. Cheson, Richard R. Furman, Nicole Lamanna, Constantine S...> ;American Journal of Hematology. 2018 Nov 1
• 1 citations
  A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies.
  Hanyin Wang, Hande H. Tuncer> ;Case Reports in Hematology. 2018 Jul 3
• 64 citations
  Umbilical Cord Mesenchymal Stem Cells Increase Expansion of Cord Blood Natural Killer Cells
  Laurent Boissel, Hande H. Tuncer, Monica Betancur, Adam Wolfberg, Hans G. Klingemann> ;Biology of Blood and Marrow Transplantation. 2008 Sep 1
• 30 citations
  Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.
  Hande H. Tuncer, Robert A. Oster, Shu T. Huang, Marisa B. Marques> ;Transfusion. 2007 Jan 1
• Join now to see all